Nephros (NEPH) Equity Ratio (2010 - 2026)

Nephros' Equity Ratio history runs 17 years deep, the most recent figure standing at 0.78 for Q1 2026.

• In Q1 2026, Equity Ratio fell 1.66% year-over-year to 0.78; the TTM figure through Mar 2026 stood at 0.78 (down 1.66% YoY), while the FY2025 annual figure was 0.75, down 2.34% from the prior year.
• Equity Ratio was 0.78 for Q1 2026 at Nephros, up from 0.75 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.86 in Q1 2022 to a low of 0.7 in Q4 2023.
• Historically, Equity Ratio has averaged 0.78 across 5 years, with a median of 0.79 in 2024.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio slipped 14.31% in 2024, then advanced 10.09% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.81 in 2022, then declined by 12.73% to 0.7 in 2023, then rose by 8.68% to 0.77 in 2024, then slipped by 2.34% to 0.75 in 2025, then climbed by 3.73% to 0.78 in 2026.
• The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.75 (Q4 2025), and 0.76 (Q3 2025), per Business Quant data.